Skip to main content
Log in

Effect of Vitamin E Deficiency on Rat Brain Monoamine Metabolism

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

We investigated the effects of vitamin E deficiency on the monoamine metabolism in the rat brain. Male Wistar rats fed on the vitamin E deficient diet for 24 weeks were analyzed. At 28 weeks, they showed a reduced growth rate (52% of reduction), muscle atrophy, a motor weakness of hind limbs and disturbance of gait. The concentrations of monoamines, their precursors and metabolites in the brain were simultaneously determined using high performance liquid chromatography (HPLC) coupled with a coulometric detection with electrode array system. In addition, tryptophan hydroxylase activity was measured. The dopamine (p = 0.009) and serotonin (p = 0.04) levels in the brain stem of vitamin E deficients rats were significantly lower than in the controls, whereas their precursors tyrosine (p = 0.0009) and tryptophan (p = 0.0065) levels in the brain stem were significantly higher than in the controls. Moreover, tryptophan hydroxylase activity (p = 0.0005) in the brain stem of vitamin E deficient brains was significantly lower than in the controls. All statistical comparisons were done using non-parametric tests (Mann-Whitney U test). These results suggest that vitamin E deficiency may play a role in the disturbance of monoamine metabolism in rat brain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Götz, M. R. E., Freyberger, A., and Riederer, P. 1990. Oxidative stress: a role in the pathogenesis of Parkinson's disease. J. Neural. Transm., 29(suppl):241–249.

    Google Scholar 

  2. Marsden, C. D. 1990. Parkinson's disease. Lancet 1:948–952.

    Google Scholar 

  3. Dexter, D. T., Carter, C., Wells, F. R.,and et al. 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem., 52:381–389.

    Google Scholar 

  4. Kilinc, A., Yalcin, A. S., Yalcin, D., and et al. 1988. Increased erythrocyte susceptibility to lipid peroxidation in human Parkinson's disease. Neurosci. Lett., 87:307–310.

    Google Scholar 

  5. Pall, H. S., Williams, A. C., Blake, D. R., and et al. 1986. Lipid peroxidation and Parkinson's disease (letter). Lancet, 1:870–871.

    Google Scholar 

  6. Smith, M. R., Sandy, M. S., and Di Monte, D. 1987. Free radicals, lipid peroxidation and Parkinson's diseas (letter). Lancet 1:38.

    Google Scholar 

  7. Poirier, J., and Barbeau, A. 1987. Erythrocyte antioxidant activity in human patients with Parkinson's disease. Neurosci Lett., 75:345–348.

    Google Scholar 

  8. Ambani, L. M., Van Woert, M. N., and Murphy, S. 1975. Brain peroxidase and catalase in Parkinson's disease. Arch. Neurol., 32:114–118.

    Google Scholar 

  9. Kish, S. J., Morito, C., and Hornykiewicz, O. 1985. Glutathion peroxidase activity in Parkinson's disease. Neurosci. Lett., 58:343–346.

    Google Scholar 

  10. Perry, T.L., Godin, D.V., and Hansen, S. 1982. Parkinson's disease: a disorder due to nigral glutathion deficiency? Neurosci., Lett. 33:305–310.

    Google Scholar 

  11. Riederer, P., Sofic, E., Rausch, W. D., and et al. 1989. Transition metals, ferritine, glutathion, and ascorbic acid in parkinsonian brains. J. Neurochem., 52:515–520.

    Google Scholar 

  12. Friedrich, W. 1988. Vitamin E. Pages 219–286, in Friedrich, W. (ed), Vitamins, Walter de Gruyter, Berlin.

    Google Scholar 

  13. Grimes, J. D., Hassan, M.N., and Thakar, J. 1987. Antioxidant therapy in Parkinson's disease. Can. J. Neurol. Sci., 14(supple): 483–487.

    Google Scholar 

  14. Muller, D. P. R., Lyond, J.K., and Wolff, O. H. 1983. Vitamin E and neurological function. Lancet, 1:225–228.

    Google Scholar 

  15. Halliwall, B., and Gutteridge, J. M. C. 1990. The antioxidants of human extracellular fluids. Arch. Biochem. Biophys., 280:1–8.

    Google Scholar 

  16. Driskell, W.J., Neese, J.W., Bryant, C.C., and et al. 1982. Measurement of vitamin A and vitamin E in human serum by high performance liquid chromatography. J. Chromatogr., 231:439–444.

    Google Scholar 

  17. Siuciak, J. A., Gamache, P. H., and Dubocovich, M. L. 1992. Monoamines and their precursors and metabolites in the chicken brain, pineal and retina: regional distribution and day/night variations. J. Neurochem., 58(2):722–729.

    Google Scholar 

  18. Paxinos, G., and Watson, C. 1986. The rat brain in stereotaxic coordinates, in Paxinos G, and Watson C (eds), Academic Press, Australia.

    Google Scholar 

  19. Fujisawa, H., and Nakata, H. 1987. Tryptophan 5-monooxygenase from rat brain stem. Methods in Enzymology., 142:83–86.

    Google Scholar 

  20. Nagatsu, T., Oka, K., and Kato, T. 1979. Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J. Chromatogr., 163:247–252.

    Google Scholar 

  21. Golbe, L. I., Farrell, T. M., and Davis, P. H. 1988. Case-control study of early life dietary factors in Parkinson's disease. Arch. Neurol., 45:1350–1353.

    Google Scholar 

  22. Golbe, L. I., Farrell, T. M., and Davis, P. H. 1990. Follow-up study on early life protective and risk factors in Parkinson's disease. Mov. Disord., 5:66–70.

    Google Scholar 

  23. Férnandez-Calle, P., Molina, J. A., Jiménez-Jiménez, F. J., and et al. 1992. Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease. Neurology, 42:1064–1066.

    Google Scholar 

  24. Fahn, S. 1989. The endogeneous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high dosage antioxidants in an attempt to slow the progression of the illness. Ann. NY. Acad. Sci., 570:186–196.

    Google Scholar 

  25. Perry, T. L., Yong, R. M., Clavier, K., and et al. 1985. Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine by four different antioxidants in the mouse. Neurosci. Lett., 63:56–60.

    Google Scholar 

  26. Yong, W. W., Perry, T. L., and Krisman, A. A. 1986. Deletion of glutathione in brain stem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment. Neurosci. Lett., 63:56–60.

    Google Scholar 

  27. Martinovits, G., Melamed, E., Cohen, O., and et al. 1986. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP). Neurosci. Lett., 69:192–197.

    Google Scholar 

  28. Perry, T. L., Yong, V. W., Hansen, S., and et al. 1987. α-Tocophenol and β-carotene do not protect marmosets against the dopaminergic neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurol. Sci., 81:321–331.

    Google Scholar 

  29. Odunze, I. N., Klaidman, L. K., and Adams, J. D. Jr. 1990. MPTP toxicity in the mouse brain and vitamin E. Neurosci. Lett., 108:346–349.

    Google Scholar 

  30. Adams, J. D. Jr., Odunze, I. N., and Sevanian, A. 1990. Induction by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of lipid peroxidation in vivo in vitamin E deficient mice. Biochem. Pharmacol., 39:R5-R8.

    Google Scholar 

  31. MacEvilly, C., and Muller, D. P. R. 1996. Lipid peroxidation in neural tissues and fractions from vitamin E-deficient rats. Free. Radic. Biol. Med., 20(5):639–648.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adachi, K., Izumi, M. & Mitsuma, T. Effect of Vitamin E Deficiency on Rat Brain Monoamine Metabolism. Neurochem Res 24, 1307–1311 (1999). https://doi.org/10.1023/A:1020937409855

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020937409855

Navigation